eLifeNeurosciencePeer-reviewed journal article
Opioid antagonism reduces wanting by strengthening frontostriatal connectivity
Alexander SoutschekiD, Susanna C. Weber, Thorsten KahntiD, Boris B. QuednowiD, Philippe N. TobleriD
Abstract
Goal-directed behavior depends on both motivational ("wanting") and hedonic ("liking") dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown as to how the different brain regions and neurotransmitter systems interact in processing distinct reward dimensions. Here, we assessed how pharmacological manipulations of opioid and dopamine receptor activation modulate the neural processing of wanting and liking in humans in a randomized, placebo-controlled, double-blind clinical trial. Blocking opioid receptor activation with naltrexone selectively reduced wanting of rewards, which on a neural level was reflected by stronger coupling between dorsolateral prefrontal cortex and the striatum under naltrexone compared with placebo. Our findings thus provide insights into how opioid receptors mediate frontostriatal gating of specifically motivational, not hedonic, aspects of rewards.
- Citations
- 14
- FWCI
- 1.04
- Field percentile
- top 28%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Effects of dopamine and opioid receptor antagonism on the neural processing of social and non-social rewards
Claudia Massaccesi, Sebastian Korb, … Giorgia Silani·Human Brain MappingPeer-reviewed·Mar 1, 2024
- Dopaminergic and opioidergic regulation of implicit hedonic facial reactions during anticipation and consumption of social and nonsocial rewards
Sebastian Korb, Sebastian J. Götzendorfer, … Giorgia Silani·bioRxiv·Feb 3, 2020
- Oxytocin modulates behavioral economic and dopaminergic measures of motivation to seek intravenous oxycodone in rats
Harrison L. Blount, Madison Gits, … Lori A. Knackstedt·bioRxiv·Oct 19, 2026
- Effects of dopamine D2 and opioid receptor antagonism on the trade-off between model-based and model-free behavior in healthy volunteers
Nace Mikuš, Sebastian Korb, … Christoph D. Mathys·eLifePeer-reviewed·Nov 23, 2022
- Loss of mu and delta opioid receptors on neurons expressing dopamine receptor D1 has no effect on reward sensitivity
Zofia Harda, Jadwiga Spyrka, … Jan M. Rodriguez Parkitna·NeuropharmacologyPeer-reviewed·Sep 15, 2020
- Neural signatures of opioid-induced risk-taking behavior in the prelimbic prefrontal cortex
Cana B. Quave, Andres M. Vasquez, … Fabricio H Do Monte·bioRxiv·Feb 5, 2024